Abstract: In vitro antitumor activity of some 4-(2-hydroxyaryl)-1,2,3-thidiazoles was studied against erythroleukemia (K562) and cervical carcinoma (HeLa) cell lines.

Original languageEnglish
Pages (from-to)2400-2404
Number of pages5
JournalRussian Journal of General Chemistry
Volume90
Issue number12
DOIs
StatePublished - Dec 2020

    Research areas

  • 4-(2-hydroxyaryl)-1,2,3-thidiazoles, cervical carcinoma (HeLa) cell line, erythroleukemia (K562) cell line, in vitro antitumor activity

    Scopus subject areas

  • Chemistry(all)

ID: 74411806